Executive Summary for FCC Comments.pdf
Submitted by: John Coates, Founder, RF Safe
Subject: Non-Thermal, Nonlinear, and Tissue-Specific EMF Mechanisms
The Federal Communications Commission (FCC) is currently operating under an unresolved 2021 mandate from the D.C. Circuit Court of Appeals, which found the agency’s reliance on 1996-era, thermal-only exposure limits to be arbitrary and capricious regarding non-cancer health effects. The Commission cannot lawfully expand federal preemption, accelerate infrastructure approvals, or rely on existing RF compliance determinations as a complete answer to health and environmental objections while material scientific questions remain actively ignored.
For decades, the FCC and the telecom industry have defended thermal-only standards by arguing that non-thermal biological effects lacked a defined molecular mechanism or “transducer”. As of 2026, that defense is scientifically obsolete. The scientific record now includes specific, mathematically defined, and falsifiable molecular targets that make non-thermal bioeffects experimentally tractable.
These comments detail the urgent biophysical realities the FCC and the Department of Health and Human Services (HHS) must now address:
-
The Missing Transducers Have Been Identified: Recent peer-reviewed evidence, including a landmark 2026 publication in Cell, identifies specific cellular hardware as direct EMF sensors. This includes the mitochondrial protein CYB5B, which mediates EMF-responsive calcium oscillations , and the S4 voltage sensors located in voltage-gated ion channels (VGICs).
-
The “Average Power” Fallacy: The FCC’s compliance structure measures time-averaged SAR and power density, metrics designed solely to prevent bulk tissue heating over 6 to 30 minutes. However, biologically relevant exposure is dictated by the low-frequency modulation envelope, pulse repetition, and duty cycle (such as the ~9.77 Hz Wi-Fi beacon periodicity). Low-frequency EMF pulses induce nanometer-scale ion displacements that generate enough Coulomb force to physically jam the cell’s S4 voltage doors. Using time-averaged heat metrics to assess the disruption of biological timing fidelity is scientifically invalid.
-
Tissue-Specific Susceptibility (Density Gating): Biological risk from EMF is not uniform across the body. Tissues with the highest density of mitochondria, excitable membranes, and calcium-redox machinery—specifically the heart, brain, and developing nervous systems—are disproportionately vulnerable to this localized bioelectric jamming. This “density gating” hypothesis provides a coherent explanation for the specific target-organ tumors (gliomas and cardiac schwannomas) observed in major animal studies and genetic profiling.
-
The Statutory Duty Under Public Law 90-602: The FCC cannot treat these non-thermal biological realities as someone else’s problem. Under Public Law 90-602, HHS and the FDA have an explicit statutory mandate to conduct research, evaluate exposure conditions, and develop performance standards to protect the public from electronic product radiation.
Conclusion and Demand: The FCC must stop pretending that the only scientifically relevant question is tissue heating. The Commission should defer any expansion of wireless deployment preemption until HHS and the FDA complete a transparent, independent review of these newly identified non-thermal mechanisms—including the S4/VGIC model, CYB5B redox pathways, and tissue-specific density gating. Proceeding without this coordinated evaluation perpetuates the exact analytical failure already remanded by the D.C. Circuit.
